Completing data — refresh the page later to see the latest
99260-67-0CC1OC(OC2CCC(OC3(C)CC(=O)C4(O)C5=C(C=CC4(O)C3)C(=O)c3c(ccc(C4CC6OC7CC(=O)C(C)OC7OC6C(C)O4)c3O)C5=O)OC2C)C=CC1=OWUQKUPKWGZHYBN-NIVOMPQSSA-Nsaquayamycin B has been reported in Streptomyces lusitanus with data available.
99260-67-0DescriptionSaquayamycin B is a glycoside of aquayamycin that acts on Gram-positive bacteria and inhibits the growth of adriamycin-sensitive and adriamycin-resistant P388 leukemia cells.
UsesSaquayamycin B (compound 3) is a new angucycline antibiotic. Saquayamycin B has antitumor activities against a human lung (H-460) and a human breast cancer cell line (MCF-7) with GI50 values of 12.2 and 15.2 μM respectively [1].